In a blog, the facility writes that MT2 isn't "currently approved by the FDA." Additionally, West Lake Dermatology says that the compound "cannot be legally marketed or sold as a drug, supplement, or cosmetic product." Further, it isn't "used in standard medical practices." It's "largely unregulated, with no reliable assurance of purity, sterility, or dosing." West Lake Dermatology writes that MT2 began its life as a peptide used for academic purposes
The pituitary gland could become less responsive to the ipamorelin signal, requiring higher doses for the same effect
Now it's being studied for MS, and psoriatic arthritis, and other autoimmune diseases
For GLP-1 users, it's a problem
Cardiovasc Diabetol 23(1):10